Medicare Limits Aduhelm Coverage to Patients in Clinical Trials January 12, 2022 Auto Bot News 0 The Centers for Medicare and Medicaid Services took action to limit prescribing and use of Biogen’s new and controversial Alzheimer’s treatment Aduhelm (aducanumab).